Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2017Chemical Society ReviewsOpen Access

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

View Full Paper
Ask AI
Bookmark
Share

Authors

LZLeli ZengSun Yat-sen UniversityPGPranav GuptaMerck & Co., Inc., Rahway, NJ, USA (United States)YCYanglu ChenColumbia University Irving Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zeng et al. (2017) studied this question.

synapsesocial.com/papers/69da21ffb48bb130d4684294https://doi.org/10.1039/c7cs00195a
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid2012 · 298 citations
  2. 2Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes2011 · 104 citations
  3. 3Subcellular Localization and Transport Kinetics of Ruthenium Organometallic Anticancer Compounds in Living Cells: A Dose-Dependent Role for Amino Acid and Iron Transporters2014 · 51 citations
  4. 4Metallomics insights into the programmed cell death induced by metal-based anticancer compounds2014 · 121 citations
  5. 5The Contrasting Activity of Iodido versus Chlorido Ruthenium and Osmium Arene Azo- and Imino-pyridine Anticancer Complexes: Control of Cell Selectivity, Cross-Resistance, p53 Dependence, and Apoptosis Pathway2013 · 221 citations